Remix Therapeutics
- Founded: 2019
- Location: Cambridge, MA
- Employee range: 50 - 200
- Clinical stage: RD
- Therapy area: Oncology
- Drug types: ONC, NEU, GEN
- Lead product: Undisclosed
- Product link: https://www.remixtx.com/science/
- Funding: $70M B May 2022; $81M A Dec 2020
- Investors: Surveyor, Foresite Capital, Atlas Venture, The Column Group, Arch Venture Partners, Alexandria Venture Investments, Casdin Capital
remixtx.com linkedin.com job board
Short description:
Small molecule therapies designed to reprogram RNA processing
Drug notes:
Additional undisclosed programs RD CNS diseases, genetic disorders, undisclosed
Long description:
Contact us to add description: recruit@workinbiotech.com
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com